Table 3.
In vivo antimalarial Activity against P. berghei (ANKA).
Dose (mg/kg/day × 4) | Route | % Reduction parasitaemia P. berghei ANKA GFP | Survival (days) | |
---|---|---|---|---|
20 | 50 | ipa | 12 | 6 |
Chloroquine | 10 | ip | 99.97 | 20 |
Control | 7 |
ip: intraperitoneal route of administration.